Loading clinical trials...
Loading clinical trials...
Recherche et caractérisation de Nouveaux gènes impliqués Dans la déficience Intellectuelle.
Intellectual disability (ID) occurs in 2 to 3 % of the general population but the cause is identified only in 30 to 60% of cases. The purpose of this study is to indentify genes involved in ID with new genetics tools (SNP-arrays, next generation sequencing...) and establish genotype-phenotype correlations.
Age
All ages
Sex
ALL
Healthy Volunteers
No
CRICM - UPMC/Inserm UMR_S975/CNRS UMR7225, Groupe Hospitalier de la Pitié-Salpêtrière,
Paris, France
Start Date
December 31, 2012
Primary Completion Date
December 31, 2022
Completion Date
December 31, 2022
Last Updated
January 23, 2025
8,500
ACTUAL participants
gene analysis
GENETIC
Lead Sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06555965